中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 3
Mar.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(3): 621-626

Influence of high-density lipoprotein cholesterol on the prognosis of patients with alcohol-related hepatocellular carcinoma after radical treatment

DOI: 10.3969/j.issn.1001-5256.2021.03.023
  • 1.

    Comprehensive Liver Cancer Center, Peking University 302 Clinical Medical School, Beijing 100039, China

  • 2.

    Comprehensive Liver Cancer Center, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China

  • Received Date: 2020-09-07
  • Accepted Date: 2020-11-13
  • Published Date: 2021-03-20
    Abstract
  •   Objective  To investigate the association of high-density lipoprotein cholesterol (HDL-C) with the prognosis of patients with alcohol-related hepatocellular carcinoma (HCC) after radical treatment.  Methods  A retrospective analysis was performed for the clinical data of 43 patients with alcohol-related HCC who were admitted to The Fifth Medical Center of Chinese PLA General Hospital and underwent radical treatment from January 2008 to July 2015, and according to HDL-C level, the patients were divided into normal group with 26 patients and abnormal group with 17 patients. The two groups were compared in terms of basic information, laboratory markers, imaging indices, Barcelona Clinic Liver Cancer tumor stage, and Child-Pugh class of liver function. The t-test test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups; the chi-square test was used for comparison of categorical data between two groups. The Kaplan-Meier method was used to plot survival curves and the log-rank test was used for comparison between groups. Univariate and multivariate Cox proportional hazards models were used to analyze independent risk factors for prognosis.  Results  There was a significant difference in prealbumin between the two groups (162.38±60.86 mg/L vs 120.06±64.08 mg/L, t=2.184, P=0.035). Number of tumors (hazard ratio [HR]=2.839, 95%confidence interval [CI]: 1.120~7.200, P=0.028), tumor size (HR=2.634, 95%CI: 1.062~6.529, P=0.037), and HDL-C level (HR=2.400, 95%CI: 1.040~5.537, P=0.040) were independent risk factors for the overall survival of patients with alcohol-related HCC. There were significant differences in 1-, 3-, and 5-year cumulative survival rates between the normal group and the abnormal group (88.5%/72.4%/55.7% vs 70.6%/43.7%/17.5%, χ2=5.881, P=0.015).  Conclusion  The reduction in HDL-C level might indicate poor prognosis of patients with alcohol-related HCC.

     

    • FullText(HTML)
  • loading
    • References(31)
  • [1]
    BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492
    [2]
    HU JH, YUAN PZ, LI Y. The value of serum glutamate dehydrogenase and cholinesterase in the diagnosis of liver diseases[J]. Prac J Clin Med, 2019, 16(3): 115-117. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-YYLC201903036.htm

    胡江红, 袁平宗, 李勇. 血清谷氨酸脱氢酶与胆碱酯酶诊断肝脏疾病价值分析[J]. 实用医院临床杂志, 2019, 16(3): 115-117. https://www.cnki.com.cn/Article/CJFDTOTAL-YYLC201903036.htm
    [3]
    KITAHARA CM, BERRINGTON de GONZÁLEZ A, FREEDMAN ND, et al. Total cholesterol and cancer risk in a large prospective study in Korea[J]. J Clin Oncol, 2011, 29(12): 1592-1598. DOI: 10.1200/JCO.2010.31.5200
    [4]
    GAO XH, ZHANG SS, CHEN H, et al. Systemic hepatic-damage index for predicting the prognosis of hepatocellular carcinoma after curative resection[J]. Front Physiol, 2017, 8: 480. DOI: 10.3389/fphys.2017.00480
    [5]
    National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association. Diagnostic criteria of alcoholic fatty liver disease[J]. World J Infect, 2001, 1(5): 482. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-ZHGZ200302003.htm

    中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 酒精性肝病诊断标准[J]. 世界感染杂志, 2001, 1(5): 482. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHGZ200302003.htm
    [6]
    Bureau of Medical Administration, National Health Commission of the People's Republic of China. Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)[J]. J Clin Hepatol, 2020, 36(2): 277-292. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2020.02.007

    中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 临床肝胆病杂志, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007
    [7]
    LI D, ZHAO H, ZHOU H, et al. The clinical characteristics and the image presentation of CT and MRI of hepatocellular carcinoma based on alcoholic liver cirrhosis[J]. J Med Sci Cent South China, 2015, 43(6): 632-636. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-HYYY201506009.htm

    李丹, 赵衡, 周宏, 等. 酒精相关性肝细胞癌的临床特点和CT、MRI影像表现[J]. 中南医学科学杂志, 2015, 43(6): 632-636. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYY201506009.htm
    [8]
    COSTENTIN CE, MOURAD A, LAHMEK P, et al. Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study[J]. Cancer, 2018, 124(9): 1964-1972. DOI: 10.1002/cncr.31215
    [9]
    GEORGILA K, VYRLA D, DRAKOS E. Apolipoprotein A-Ⅰ (ApoA-Ⅰ), immunity, inflammation and cancer[J]. Cancers (Basel), 2019, 11(8): 1097. DOI: 10.3390/cancers11081097
    [10]
    YE J, LUO Q Y, WANG X P, et al. Serum apolipoprotein A-Ⅰ combined with C-reactive protein serves as a novel prognostic stratification system for colorectal cancer[J]. Cancer Manag Res, 2019, 11: 9265-9276. DOI: 10.2147/CMAR.S215599
    [11]
    TATEMATSU S, FRANCIS SA, NATARAJAN P, et al. Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium[J]. Arterioscler Thromb Vasc Biol, 2013, 33(8): 1788-1794. DOI: 10.1161/ATVBAHA.113.301300
    [12]
    QIAO XW. Detection and analysis of blood lipid level in patients with liver cancer[J]. Chron Pathematol J, 2010, 12(10): 1242, 1244. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-YYSO201010053.htm

    乔献伟. 肝癌患者血脂水平检测分析[J]. 慢性病学杂志, 2010, 12(10): 1242, 1244. https://www.cnki.com.cn/Article/CJFDTOTAL-YYSO201010053.htm
    [13]
    TRIEB M, RAINER F, STADLBAUER V, et al. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure[J]. J Hepatol, 2020, 73(1): 113-120. DOI: 10.1016/j.jhep.2020.01.026
    [14]
    OOI K, SHIRAKI K, SAKURAI Y, et al. Clinical significance of abnormal lipoprotein patterns in liver diseases[J]. Int J Mol Med, 2005, 15(4): 655-660. http://europepmc.org/abstract/MED/15754028
    [15]
    MOTTA M, GIUGNO I, RUELLO P, et al. Lipoprotein (a) behaviour in patients with hepatocellular carcinoma[J]. Minerva Med, 2001, 92(5): 301-305. http://www.ncbi.nlm.nih.gov/pubmed/11675573
    [16]
    FUJII S, KOGA S, SHONO T, et al. Serum apoprotein A-Ⅰ and A-Ⅱ levels in liver diseases and cholestasis[J]. Clin Chim Acta, 1981, 115(3): 321-331. DOI: 10.1016/0009-8981(81)90245-X
    [17]
    HUANG WC, CHEN X, YU JL, et al. Value of serum high-density lipoprotein cholesterol levels in evaluating liver function[J]. China Med Pharm, 2014, 4(13): 118-119, 142. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-GYKX201413044.htm

    黄文彩, 陈璇, 余洁玲, 等. 血清高密度脂蛋白胆固醇水平用于评价肝脏合成功能的价值[J]. 中国医药科学, 2014, 4(13): 118-119, 142. https://www.cnki.com.cn/Article/CJFDTOTAL-GYKX201413044.htm
    [18]
    BEEGHLY-FADIEL A, KHANKARI NK, DELAHANTY RJ, et al. A Mendelian randomization analysis of circulating lipid traits and breast cancer risk[J]. Int J Epidemiol, 2020, 49(4): 1117-1131. DOI: 10.1093/ije/dyz242
    [19]
    ZHANG D, XI Y, FENG Y. Ovarian cancer risk in relation to blood lipid levels and hyperlipidemia: A systematic review and meta-analysis of observational epidemiologic studies[J]. Eur J Cancer Prev, 2020. [Online ahead of print] http://journals.lww.com/eurjcancerprev/Fulltext/9000/Ovarian_cancer_risk_in_relation_to_blood_lipid.99122.aspx
    [20]
    SCHAIRER C, LAURENT CA, MOY LM, et al. Obesity and related conditions and risk of inflammatory breast cancer: A nested case-control study[J]. Breast Cancer Res Treat, 2020, 183(2): 467-478. DOI: 10.1007/s10549-020-05785-1
    [21]
    QU F, CHEN R, PENG Y, et al. Assessment of the predictive role of serum lipid profiles in breast cancer patients receiving neoadjuvant chemotherapy[J]. J Breast Cancer, 2020, 23(3): 246-258. DOI: 10.4048/jbc.2020.23.e32
    [22]
    GANJALI S, BANACH M, PIRRO M, et al. HDL and cancer-causality still needs to be confirmed? Update 2020[J]. Semin Cancer Biol, 2020. [Online ahead of print] http://www.sciencedirect.com/science/article/pii/S1044579X20302121
    [23]
    YU JF. Analysis of abnormal levels of blood lipid and homocysteine in patients with different types of malignant tumors[D]. Nanning: Guangxi Medical University), 2017. (in Chinese)

    余敬福. 不同类型恶性肿瘤患者血脂、同型半胱氨酸水平异常分析[D]. 南宁: 广西医科大学, 2017.
    [24]
    ZOU Y, WU L, YANG Y, et al. Serum lipid levels correlate to the progression of gastric cancer with neuroendocrine immunophenotypes: A multicenter retrospective study[J]. Transl Oncol, 2021, 14(1): 100925. DOI: 10.1016/j.tranon.2020.100925
    [25]
    BRANTLEY KD, RIIS AH, ERICHSEN R, et al. The association of serum lipid levels with colorectal cancer recurrence[J]. Cancer Epidemiol, 2020, 66: 101725. DOI: 10.1016/j.canep.2020.101725
    [26]
    YUAN B, FU J, YU WL, et al. Prognostic value of serum high-density lipoprotein cholesterol in patients with gallbladder cancer[J]. Rev Esp Enferm Dig, 2019, 111(11): 839-845. http://www.ncbi.nlm.nih.gov/pubmed/31595756
    [27]
    SAITO N, SAIRENCHI T, IRIE F, et al. Low serum LDL cholesterol levels are associated with elevated mortality from liver cancer in Japan: The Ibaraki Prefectural health study[J]. Tohoku J Exp Med, 2013, 229(3): 203-211. DOI: 10.1620/tjem.229.203
    [28]
    ZHAN CL. Serum makers of lipid metabolism as a new prognostic factor in cancer: A meta-analysis[D]. Suzhou: Soochow University, 2019. (in Chinese)

    湛长丽. 血清脂代谢标志物作为恶性肿瘤预后预测因子的Meta分析[D]. 苏州: 苏州大学, 2019.
    [29]
    JIANG SS, WENG DS, JIANG L, et al. The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma[J]. J Cancer, 2016, 7(6): 626-632. DOI: 10.7150/jca.13837
    [30]
    CARR BI, GIANNELLI G, GUERRA V, et al. Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients[J]. Int J Biol Markers, 2018, 33(4): 423-431. DOI: 10.1177/1724600818776838
    [31]
    ZHONG GC, HUANG SQ, PENG Y, et al. HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: A pooled analysis of 37 prospective cohort studies[J]. Eur J Prev Cardiol, 2020, 27(11): 1187-1203. DOI: 10.1177/2047487320914756
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (387) PDF downloads(16) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return